BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27013698)

  • 1. 99mTc-Glu-c(RGDyK)-Bombesin SPECT Can Reduce Unnecessary Biopsy of Masses That Are BI-RADS Category 4 on Ultrasonography.
    Ji T; Gao S; Liu Z; Xing H; Zhao G; Ma Q
    J Nucl Med; 2016 Aug; 57(8):1196-200. PubMed ID: 27013698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic role of 99mTc-dual receptor targeted probe and targeted peptide bombesin (RGD-BBN) SPET/CT in the detection of malignant and benign breast tumors and axillary lymph nodes compared to ultrasound.
    Ji T; Sun Y; Chen B; Ji B; Gao S; Ma Q; Cheng G; Zhang H
    Hell J Nucl Med; 2015; 18(2):108-13. PubMed ID: 26187209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An exploratory study on 99mTc-RGD-BBN peptide scintimammography in the assessment of breast malignant lesions compared to 99mTc-3P4-RGD2.
    Chen Q; Ma Q; Chen M; Chen B; Wen Q; Jia B; Wang F; Sun B; Gao S
    PLoS One; 2015; 10(4):e0123401. PubMed ID: 25849333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 99mTc-labeled RGD-BBN peptide for small-animal SPECT/CT of lung carcinoma.
    Liu Z; Huang J; Dong C; Cui L; Jin X; Jia B; Zhu Z; Li F; Wang F
    Mol Pharm; 2012 May; 9(5):1409-17. PubMed ID: 22452411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of (99m)Tc-3PRGD2 scintimammography for differentiation of malignant from benign breast lesions: Comparison of visual and semi-quantitative analysis.
    Chen Q; Xie Q; Zhao M; Chen B; Gao S; Zhang H; Xing H; Ma Q
    Hell J Nucl Med; 2015; 18(3):193-8. PubMed ID: 26574690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Pivotal Study of Optoacoustic Imaging to Diagnose Benign and Malignant Breast Masses: A New Evaluation Tool for Radiologists.
    Neuschler EI; Butler R; Young CA; Barke LD; Bertrand ML; Böhm-Vélez M; Destounis S; Donlan P; Grobmyer SR; Katzen J; Kist KA; Lavin PT; Makariou EV; Parris TM; Schilling KJ; Tucker FL; Dogan BE
    Radiology; 2018 May; 287(2):398-412. PubMed ID: 29178816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BI-RADS 3, 4, and 5 lesions: value of US in management--follow-up and outcome.
    Raza S; Chikarmane SA; Neilsen SS; Zorn LM; Birdwell RL
    Radiology; 2008 Sep; 248(3):773-81. PubMed ID: 18647850
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Zhang J; Mao F; Niu G; Peng L; Lang L; Li F; Ying H; Wu H; Pan B; Zhu Z; Chen X
    Theranostics; 2018; 8(4):1121-1130. PubMed ID: 29464003
    [No Abstract]   [Full Text] [Related]  

  • 9. Shear-wave elastography improves the specificity of breast US: the BE1 multinational study of 939 masses.
    Berg WA; Cosgrove DO; Doré CJ; Schäfer FK; Svensson WE; Hooley RJ; Ohlinger R; Mendelson EB; Balu-Maestro C; Locatelli M; Tourasse C; Cavanaugh BC; Juhan V; Stavros AT; Tardivon A; Gay J; Henry JP; Cohen-Bacrie C;
    Radiology; 2012 Feb; 262(2):435-49. PubMed ID: 22282182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shear-wave elastography and greyscale assessment of palpable probably benign masses: is biopsy always required?
    Giannotti E; Vinnicombe S; Thomson K; McLean D; Purdie C; Jordan L; Evans A
    Br J Radiol; 2016 Jun; 89(1062):20150865. PubMed ID: 27007593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of quantitative shear wave elastography in the evaluation of solid breast masses: determination of the most discriminatory parameter.
    Au FW; Ghai S; Moshonov H; Kahn H; Brennan C; Dua H; Crystal P
    AJR Am J Roentgenol; 2014 Sep; 203(3):W328-36. PubMed ID: 25148191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downgrading and Upgrading Gray-Scale Ultrasound BI-RADS Categories of Benign and Malignant Masses With Optoacoustics: A Pilot Study.
    Neuschler EI; Lavin PT; Tucker FL; Barke LD; Bertrand ML; Böhm-Vélez M; Destounis S; Dogan BE; Grobmyer SR; Katzen J; Kist KA; Makariou EV; Parris TM; Young CA; Butler R
    AJR Am J Roentgenol; 2018 Sep; 211(3):689-700. PubMed ID: 29975115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Inter-Observer Variability and Diagnostic Performance of the Fifth Edition of BI-RADS for Breast Ultrasound of Static versus Video Images.
    Youk JH; Jung I; Yoon JH; Kim SH; Kim YM; Lee EH; Jeong SH; Kim MJ
    Ultrasound Med Biol; 2016 Sep; 42(9):2083-8. PubMed ID: 27324292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of inversion imaging to diagnosis in differentiating malignant from benign breast masses.
    Li N; Hou Z; Wang J; Bi Y; Wu X; Zhan Y; Peng M
    BMC Med Imaging; 2023 Dec; 23(1):206. PubMed ID: 38066441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of 99mTc-bombesin scintigraphy for differentiation of malignant from benign breast lesions.
    Shariati F; Aryana K; Fattahi A; Forghani MN; Azarian A; Zakavi SR; Sadeghi R; Ayati N; Sadri K
    Nucl Med Commun; 2014 Jun; 35(6):620-5. PubMed ID: 24686248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A set of shear wave elastography quantitative parameters combined with ultrasound BI-RADS to assess benign and malignant breast lesions.
    Shi XQ; Li JL; Wan WB; Huang Y
    Ultrasound Med Biol; 2015 Apr; 41(4):960-6. PubMed ID: 25701532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential diagnosis of solitary pulmonary nodules using ⁹⁹mTc-3P₄-RGD₂ scintigraphy.
    Ma Q; Ji B; Jia B; Gao S; Ji T; Wang X; Han Z; Zhao G
    Eur J Nucl Med Mol Imaging; 2011 Dec; 38(12):2145-52. PubMed ID: 21874323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study to determine the diagnostic criteria of spiculated masses for BI-RADS MRI category 5: when to perform re-biopsy after discordant pathologic result?
    Onishi N; Kataoka M; Kanao S; Kawai M; Iima M; Ohashi A; Toi M; Togashi K
    Breast Cancer; 2017 Jan; 24(1):69-78. PubMed ID: 26832858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
    Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V
    Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of 99mTc(CO)3-BPy-RGD complex as alphav beta3 integrin receptor-targeted imaging agent.
    Zhang X; Chen X
    Appl Radiat Isot; 2007 Jan; 65(1):70-8. PubMed ID: 17011200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.